UTI GROUP financials
UTI GROUP
969500KB7P0M43DNUN56 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Employee benefits expense | €10.2M | €10.7M |
| Raw materials & consumables used | €10.4M | €9.1M |
| Operating profit (EBIT) | -€712.0K | -€6.9M |
| Profit before tax | -€871.0K | -€7.1M |
| Income tax expense | -€203.0K | -€382.0K |
| Profit for the year | -€668.0K | -€6.7M |
| — attributable to owners | -€668.0K | -€6.7M |
| — attributable to NCI | €0 | €0 |
| Total comprehensive income | -€657.0K | -€6.7M |
| Per share | ||
| Basic EPS | €-0.01 | €-0.61 |
| Diluted EPS | €-0.01 | €-0.61 |
| Cash flow statement | ||
| Net cash from operating activities | -€718.0K | -€531.0K |
| Net cash from investing activities | -€747.0K | €38.0K |
| Net cash from financing activities | €1.7M | €922.0K |
| Proceeds from borrowings | €0 | €0 |
| Repayments of borrowings | €282.0K | €324.0K |
| Lease liability payments | €348.0K | €333.0K |
| Balance sheet | ||
| Total assets | €12.9M | €9.5M |
| Non-current assets | €8.6M | €6.8M |
| Property, plant & equipment | €22.0K | €12.0K |
| Right-of-use assets | €2.1M | €1.2M |
| Intangible assets & goodwill | €5.2M | €4.5M |
| Current assets | €4.3M | €2.8M |
| Trade & other receivables | €1.3M | €529.0K |
| Cash & equivalents | €1.5M | €1.2M |
| Total equity | €518.0K | -€516.0K |
| — attributable to owners | €518.0K | -€516.0K |
| Non-controlling interests | €0 | €0 |
| Non-current liabilities | €3.0M | €2.4M |
| Long-term borrowings | €500.0K | €593.0K |
| Lease liabilities (non-current) | €1.9M | €1.0M |
| Current liabilities | €9.3M | €7.7M |
| Lease liabilities (current) | €199.0K | €402.0K |
| Derived metrics | ||
| Operating margin | -3.3% | -32.9% |
| Net margin | -3.1% | -32.4% |
| Return on equity | -129.0% | 1305.6% |
| Cash conversion ratio | 1.07× | 0.08× |
| Other reported items | ||
| Adjustments For Fair Value Gains Losses | €8.0K | €10.0K |
| Adjustments For Income Tax Expense | -€203.0K | -€382.0K |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €2.0K | €38.0K |
| Adjustments For Sharebased Payments | €0 | €0 |
| Borrowing Costs Recognised As Expense | €179.0K | €251.0K |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €1.5M | €1.2M |
| Cash Flows From Used In Operations Before Changes In Working Capital | -€529.0K | -€861.0K |
| Deferred Tax Assets | €1.0M | €796.0K |
| Equity and Liabilities | €12.9M | €9.5M |
| Income Taxes Paid Refund Classified As Operating Activities | €26.0K | €46.0K |
| Increase Decrease In Cash and Cash Equivalents | €250.0K | €430.0K |
| Increase Decrease In Working Capital | €163.0K | -€376.0K |
| Increase Decrease Through Appropriation of Retained Earnings | €4.0M | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €0 | €0 |
| Increase Decrease Through Transfers and Other Changes Equity | -€10.0K | -€20.0K |
| Increase Decrease Through Treasury Share Transactions | €0 | -€7.0K |
| Intangible Assets Other Than Goodwill | €0 | €1.0K |
| Interest Income On Cash and Cash Equivalents | €0 | €0 |
| Issue of Equity | €1.7M | €2.5M |
| Issued Capital | €638.0K | €4.3M |
| Noncurrent Financial Assets | €284.0K | €272.0K |
| Noncurrent Provisions | €639.0K | €714.0K |
| Other Comprehensive Income | €11.0K | €5.0K |
| Other Current Assets | €1.5M | €1.0M |
| Other Current Liabilities | €4.4M | €3.7M |
| Other Finance Income Cost | €20.0K | -€10.0K |
| Proceeds From Issuing Shares | €442.0K | €0 |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €21.0K | €25.0K |
| Reduction of Issued Capital | €4.0M | — |
| Retained Earnings Profit Loss For Reporting Period | -€668.0K | -€6.7M |
| Revenue From Contracts With Customers | €21.6M | €20.8M |
| Services Expense | €1.3M | €1.6M |
| Share Premium | €4.0M | €2.7M |
| Tax Expense Other Than Income Tax Expense | €268.0K | €254.0K |
| Trade and Other Current Payables To Trade Suppliers | €3.7M | €2.8M |
Every line item above is a fact tagged in UTI GROUP's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.